2020
DOI: 10.29220/csam.2020.27.1.001
|View full text |Cite
|
Sign up to set email alerts
|

Statistical tests for biosimilarity based on relative distance between follow-on biologics for ordinal endpoints

Abstract: Investigations of biosimilarity between reference drugs and test drugs required statistical tests; in addition, statistical tests to evaluate biosimilarity have been recently proposed. Ordinal outcome data has been observed in research; however, appropriate statistical tests to deal with ordinal endpoints for biosimilar have not yet been proposed. This paper extends existing design for ordinal endpoints. Using measure of nominal-ordinal association and relative distances between drugs are defined so that testi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…Further diagnostic checks via hypothesis tests could tell if lack of fit does exist or not. For instance, the tests suggested in Fagerland and Hosmer (2016), see also Jeong and Lee (2009); Yoo and Kim (2020).…”
Section: Empirical Applicationmentioning
confidence: 99%
“…Further diagnostic checks via hypothesis tests could tell if lack of fit does exist or not. For instance, the tests suggested in Fagerland and Hosmer (2016), see also Jeong and Lee (2009); Yoo and Kim (2020).…”
Section: Empirical Applicationmentioning
confidence: 99%
“…Further diagnostic checks via hypothesis tests could tell if lack of fit does exist or not. For instance, the tests suggested in Fagerland and Hosmer (2016), see also Jeong and Lee (2009); Yoo and Kim (2020).…”
Section: Empirical Applicationmentioning
confidence: 99%